Table 2.
Prescription patterns by 60-day adherence to novel opioid alternatives.
| Overall |
Adherence at 60 days |
p-value |
|||
|---|---|---|---|---|---|
| Yes | No | ||||
| N = 286 | N = 221 | N = 65 | |||
| Mode of Delivery (%) | Delivery | 121 (42.3) | 103 (46.6) | 18 (27.7) | 0.025 |
| Pick up | 109 (38.1) | 78 (35.3) | 31 (47.7) | ||
| Unknown | 56 (19.6) | 40 (18.1) | 16 (24.6) | ||
| Dispensed without Interruption (%) | No | 159 (55.6) | 116 (52.5) | 43 (66.2) | 0.070 |
| Yes | 127 (44.4) | 105 (47.5) | 22 (33.8) | ||
| Type of opioid (%) | Hydromorphone | 274 (95.8) | 211 (95.5) | 63 (96.9) | 0.196 |
| Hydromorphone and Fentanyl Patch | 1 (0.3) | 0 (0.0) | 1 (1.5) | ||
| M-Eslon | 2 (0.7) | 2 (0.9) | 0 (0.0) | ||
| oxycodone | 9 (3.1) | 8 (3.6) | 1 (1.5) | ||
| Days on Opioid Prescription (mean (SD)) | 108.43 (62.32) | 133.28 (45.35) | 23.94 (29.03) | <0.001 | |
| Days on Opioid Prescription (%) | 60 days or more | 220 (76.9) | 218 (98.6) | 2 (3.1) | <0.001 |
| Less than 60 days | 66 (23.1) | 3 (1.4) | 63 (96.9) | ||
| Maximum Daily Dose Opioid – Morphine Equivalent (mean (SD)) | 346.59 (192.76) | 371.43 (199.55) | 262.15 (138.60) | <0.001 | |
| Co-prescribed OAT at baseline (%) | No | 26 (9.1) | 19 (8.6) | 7 (10.8) | 0.07 |
| Started | 123 (43.0) | 88 (39.8) | 35 (53.8) | ||
| Yes | 137 (47.9) | 114 (51.6) | 23 (35.4) | ||
| Active OAT Prescription at 60-days (%) | No | 124 (43.4) | 77 (34.8) | 47 (72.3) | <0.001 |
| Not prescribed OAT | 26 (9.1) | 19 (8.6) | 7 (10.8) | ||
| Yes | 136 (47.6) | 125 (56.6) | 11 (16.9) | ||